Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED)
This study has been completed.
Study NCT00848484 Information provided by Merck Sharp & Dohme Corp.
First Received on February 19, 2009. Last Updated on November 7, 2014
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Delirium, Dementia, Amnestic, Cognitive Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers